Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

NCT00570622 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis
Ascites
Portal Hypertension

Interventions

DRUG: Pioglitazone
DRUG: Placebo

Sponsor

Medical University of Vienna